In contrast, pathways that were promoting tumorigeneses, like those related to glioma, melanoma, and colorectal cancer, and the p53 signaling pathway, were dramatically upregulated in the high-SYK group, implying that abnormally elevated SYK may be a potential tumor promoter (Figures 8C, D). The gene discussed is SYK; the disease is glioma.